XML 128 R84.htm IDEA: XBRL DOCUMENT v3.3.0.814
INVESTMENTS - Recognition and Measurement of OTTI (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
OTTI on Investments disclosures        
Total OTTI losses recognized during the period $ 1 $ 11 $ 1 $ 13
Less: Impairments recognized in AOCI [1] 0 8 0 8
Net impairment losses recognized in earnings for securities that the Company does not intend to sell nor will likely be required to sell 1 3 1 5
Impairment losses recognized in earnings for securities that the Company intends to sell or more- likely-than-not will be required to sell before recovery 79 88 194 324
Net impairment losses recognized in earnings [1] 80 91 195 329
Securities available-for-sale (AFS)        
OTTI on Investments disclosures        
Total OTTI losses recognized during the period 1 11 1 13
Less: Impairments recognized in AOCI 0 8 0 8
Net impairment losses recognized in earnings for securities that the Company does not intend to sell nor will likely be required to sell 1 3 1 5
Impairment losses recognized in earnings for securities that the Company intends to sell or more- likely-than-not will be required to sell before recovery 64 88 152 324
Net impairment losses recognized in earnings 65 91 153 329
Held-to-maturity Securities        
OTTI on Investments disclosures        
Total OTTI losses recognized during the period 0 0 0 0
Less: Impairments recognized in AOCI 0 0 0 0
Net impairment losses recognized in earnings for securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for securities that the Company intends to sell or more- likely-than-not will be required to sell before recovery 14 0 36 0
Net impairment losses recognized in earnings 14 0 36 0
Other assets        
OTTI on Investments disclosures        
Total OTTI losses recognized during the period 0 0 0 0
Less: Impairments recognized in AOCI 0 0 0 0
Net impairment losses recognized in earnings for securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for securities that the Company intends to sell or more- likely-than-not will be required to sell before recovery 1 0 6 0
Net impairment losses recognized in earnings $ 1 $ 0 $ 6 $ 0
[1] Certain prior-period revenue and expense lines and totals were reclassified to conform to the current period’s presentation. See Note 3 to the Consolidated Financial Statements.